Randomized Phase II Study of Afatinib Plus Simvastatin Versus Afatinib Alone in Previously Treated Patients with Advanced Nonadenocarcinomatous Non-small Cell Lung Cancer
Youngjoo Lee, Ki Hyeong Lee, Geon Kook Lee, Soo-Hyun Lee, Kun Young Lim, Jungnam Joo, Yun Jung Go, Jin Soo Lee, Ji-Youn Han
Cancer Res Treat. 2017;49(4):1001-1011.   Published online 2017 Jan 13     DOI: https://doi.org/10.4143/crt.2016.546
Citations to this article as recorded by Crossref logo
Lipid metabolism and cancer
Xueli Bian, Rui Liu, Ying Meng, Dongming Xing, Daqian Xu, Zhimin Lu
Journal of Experimental Medicine.2021;[Epub]     CrossRef
Adjuvant statin therapy for oesophageal adenocarcinoma: the STAT-ROC feasibility study
L. Alexandre, A. B. Clark, S. Walton, M. P. Lewis, B. Kumar, E. C. Cheong, H. Warren, S. S. Kadirkamanathan, S. L. Parsons, S. M. Dresner, E. Sims, M. Jones, M. Hammond, M. Flather, Y. K. Loke, A. M. Swart, A. R. Hart
BJS Open.2020; 4(1): 59.     CrossRef
Whether statin use improves the survival of patients with glioblastoma?
Yonglin Xie, Qin Lu, Cameron Lenahan, Shuxu Yang, Daoyang Zhou, Xuchen Qi
Medicine.2020; 99(9): e18997.     CrossRef
Fluvastatin potentiates anticancer activity of vorinostat in renal cancer cells
Kazuki Okubo, Makoto Isono, Kosuke Miyai, Takako Asano, Akinori Sato
Cancer Science.2020; 111(1): 112.     CrossRef
Repurposing of drugs approved for cardiovascular diseases: Opportunity or mirage?
Paolo Gelosa, Laura Castiglioni, Marina Camera, Luigi Sironi
Biochemical Pharmacology.2020; 177: 113895.     CrossRef
Attenuation of the pro-inflammatory signature of lung cancer-derived mesenchymal stromal cells by statins
Sabine Galland, Patricia Martin, Giulia Fregni, Igor Letovanec, Ivan Stamenkovic
Cancer Letters.2020; 484: 50.     CrossRef
Efficacy and safety profile of statins in patients with cancer: a systematic review of randomised controlled trials
John P. Thomas, Yoon K. Loke, Leo Alexandre
European Journal of Clinical Pharmacology.2020; 76(12): 1639.     CrossRef
Statins as Anticancer Agents in the Era of Precision Medicine
Joseph Longo, Jenna E. van Leeuwen, Mohamad Elbaz, Emily Branchard, Linda Z. Penn
Clinical Cancer Research.2020; 26(22): 5791.     CrossRef
Dipyridamole Enhances the Cytotoxicities of Trametinib against Colon Cancer Cells through Combined Targeting of HMGCS1 and MEK Pathway
Sheng Zhou, Huanji Xu, Qiulin Tang, Hongwei Xia, Feng Bi
Molecular Cancer Therapeutics.2020; 19(1): 135.     CrossRef
Repurposed Drugs Trials by Cancer Type
Joseph C. Murray, Benjamin Levy
The Cancer Journal.2019; 25(2): 127.     CrossRef
Diverse Stakeholders of Tumor Metabolism: An Appraisal of the Emerging Approach of Multifaceted Metabolic Targeting by 3-Bromopyruvate
Saveg Yadav, Shrish Kumar Pandey, Yugal Goel, Mithlesh Kumar Temre, Sukh Mahendra Singh
Frontiers in Pharmacology.2019;[Epub]     CrossRef
Therapeutic effects of statins against lung adenocarcinoma via p53 mutant-mediated apoptosis
Cheng-Wei Chou, Ching-Heng Lin, Tzu-Hung Hsiao, Chia-Chien Lo, Chih-Ying Hsieh, Cheng-Chung Huang, Yuh-Pyng Sher
Scientific Reports.2019;[Epub]     CrossRef
Drug Repurposing of Metabolic Agents in Malignant Glioma
Corinna Seliger, Peter Hau
International Journal of Molecular Sciences.2018; 19(9): 2768.     CrossRef
The Effect of Statin Added to Systemic Anticancer Therapy: A Meta-Analysis of Randomized, Controlled Trials
Hyun Jang, Hyeong Kim, Jung Kim, Jin Lee
Journal of Clinical Medicine.2018; 7(10): 325.     CrossRef
Statin therapy in the treatment of active cancer: A systematic review and meta-analysis of randomized controlled trials
Mohammed A. M. Farooqi, Nikita Malhotra, Som D. Mukherjee, Stephanie Sanger, Sukhbinder K. Dhesy-Thind, Peter Ellis, Darryl P. Leong, Robert M. Lafrenie
PLOS ONE.2018; 13(12): e0209486.     CrossRef
Synergistic effect of receptor-interacting protein 140 and simvastatin on the inhibition of proliferation and survival of hepatocellular carcinoma cells
Kun Xia, Panpan Zhang, Jian Hu, Huan Hou, Mingdi Xiong, Junping Xiong, Nianlong Yan
Oncology Letters.2018;[Epub]     CrossRef